MedPath

Social Media Intervention to Stop Nicotine and Cannabis Vaping Among Adolescents

Not Applicable
Completed
Conditions
Vaping
Interventions
Behavioral: Social Media Intervention
Registration Number
NCT04707911
Lead Sponsor
University of California, San Francisco
Brief Summary

Social media based intervention to support teens in their efforts to quit vaping.

Detailed Description

This study is a randomized controlled trial of a social media intervention to support teens in their efforts to quit vaping.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
500
Inclusion Criteria
  1. English literacy
  2. Age between 13-21 years
  3. Indicate they use social media "most" (>= 4) days per week
  4. Have vaped at least once per week in the past 30 days (90 percent of participants)
  5. Access to a computer or mobile phone with photo capability to verify abstinence from vaping
  6. Indicate they are considering quitting or are interested in quitting with the next 6 months or within the next 30 days
  7. Currently reside in California
Read More
Exclusion Criteria
  1. No English literacy
  2. Age under 13 or over 21
  3. Insufficient social media use (3 or fewer days per week)
  4. Have not vaped at least once per week in past 30 days
  5. No access to computer or mobile phone with photo capability to verify abstinence from vaping
  6. Not considering or interested in quitting vaping in the next 30 days or 6 months;
  7. Not a California resident
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Vaping InterventionSocial Media InterventionThe vaping intervention will be implemented on Instagram. Participants in the treatment condition will be assigned to groups on Instagram, where they will receive up to 3 posts per day for 30 days. Groups are facilitated by a trained Guide, working with the Principal Investigator, Co-Investigators and a Pediatrician on demand if additional expertise or clinical advice is needed. Participants will be educated about signs of nicotine dependence and if they express interest in pharmacotherapy will be encouraged to access this through their personal healthcare providers. The Instagram groups will provide educational and social support, troubleshooting and advice about nicotine replacement therapy (NRT) or other forms of treatment.
Primary Outcome Measures
NameTimeMethod
Point Prevalent Abstinence (PPA) from vaping6 months

7-day point prevalence abstinence (PPA) from all tobacco products will be assessed over the course of the study. Participants reporting no vaping in the past 7 days will be coded as abstinent. Those reporting 7-day abstinence and not using nicotine replacement therapy will be mailed saliva cotinine test kit and saliva tetrahydrocannabinol (THC) test kit for biochemical verification of abstinence.

Secondary Outcome Measures
NameTimeMethod
Change in the number of participants with reduction in vapingUp to 6 months

Reduction in vaping is defined as a decline in vaping frequency by 50 percent (%) or more.

Number of participants with at least 1 quit attemptUp to 6 months

The number of participants whom achieved at least one quit attempt during the full assessment time period will be reported.

Change in the number of vape quit attemptsUp to 6 months

The number of quit attempts will be recorded at each assessment.

Change in response on Stages of Change QuestionnaireUp to 6 months

The participants readiness to quit will be measured using the Stages of Change questionnaire - single item, which asks "Are you seriously thinking of quitting smoking?" Answers range from 'Yes, within the next 30 days', 'Yes, within the next 6 months', and 'No, not thinking of quitting'.

Change in the scores on the Ways of Quitting questionnaire (WOQ)Up to 6 months

The WOQ is a 28-item self-report instrument assessing adolescent smoking cessation strategies. For each WOQ item, respondents indicate whether they have used a given strategy (yes/no) and, if used, how helpful it was perceived to be on a five-point Likert-type scale (1= "Not helpful" to 5="Extremely helpful") with regard to several categories: Social support, Seeking assistance, Avoidance, Reduction, Substitution, Medication, Distraction, and Quit all at once (single item).

Change in the score on the Thoughts About Abstinence (TAA) QuestionnaireUp to 6 months

The adapted Thoughts About Abstinence Questionnaire (Hall et al., 1991) is a 3 item self-report questionnaire that measures: 1) desire to quit smoking, 2) expected success at quitting, 3) expected difficulty of quitting on 10-point Likert scales (e.g., 1=no desire to quit/lowest expectation/lowest level of difficulty to 10 = extreme desire to quit/highest expectation of success/highest expected difficulty)

Trial Locations

Locations (1)

University of California, San Francisco

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath